American International Group, Inc. Axsome Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$69.39 - $97.64 $10,477 - $14,743	-151 Reduced 0.85%	17,570 $1.4 Million
Q4 2023 Feb 13, 2024	BUY	$57.42 - $83.61 $9,302 - $13,544	162 Added 0.92%	17,721 $1.41 Million
Q3 2023 Nov 13, 2023	BUY	$69.25 - $82.21 $119,387 - $141,730	1,724 Added 10.89%	17,559 $1.23 Million
Q2 2023 Aug 04, 2023	BUY	$58.41 - $90.35 $21,494 - $33,248	368 Added 2.38%	15,835 $1.14 Million
Q1 2023 May 12, 2023	BUY	$58.39 - $75.0 $17,925 - $23,025	307 Added 2.03%	15,467 $954,000
Q4 2022 Feb 10, 2023	BUY	$39.94 - $79.72 $41,537 - $82,908	1,040 Added 7.37%	15,160 $1.17 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $24,484 - $47,428	679 Added 5.05%	14,120 $630,000
Q2 2022 Aug 12, 2022	SELL	$21.74 - $46.75 $7,695 - $16,549	-354 Reduced 2.57%	13,441 $515,000
Q1 2022 May 13, 2022	SELL	$23.7 - $41.39 $23,012 - $40,189	-971 Reduced 6.58%	13,795 $571,000
Q4 2021 Feb 11, 2022	SELL	$30.7 - $43.36 $13,538 - $19,121	-441 Reduced 2.9%	14,766 $558,000
Q3 2021 Nov 12, 2021	SELL	$19.91 - $68.26 $7,207 - $24,710	-362 Reduced 2.33%	15,207 $501,000
Q2 2021 Aug 13, 2021	SELL	$50.63 - $73.5 $29,314 - $42,556	-579 Reduced 3.59%	15,569 $1.05 Million
Q1 2021 May 07, 2021	BUY	$55.91 - $81.44 $2,404 - $3,501	43 Added 0.27%	16,148 $914,000
Q4 2020 Feb 12, 2021	SELL	$66.31 - $86.52 $30,635 - $39,972	-462 Reduced 2.79%	16,105 $1.31 Million
Q3 2020 Nov 04, 2020	SELL	$68.34 - $85.84 $25,832 - $32,447	-378 Reduced 2.23%	16,567 $1.18 Million
Q2 2020 Aug 12, 2020	BUY	$49.87 - $98.69 $47,875 - $94,742	960 Added 6.01%	16,945 $1.39 Million
Q1 2020 May 04, 2020	BUY	$41.2 - $101.31 $9,352 - $22,997	227 Added 1.44%	15,985 $940,000
Q4 2019 Feb 05, 2020	SELL	$16.71 - $106.24 $2,205 - $14,023	-132 Reduced 0.83%	15,758 $1.63 Million
Q3 2019 Nov 08, 2019	BUY	$20.24 - $29.16 $8,217 - $11,838	406 Added 2.62%	15,890 $322,000
Q2 2019 Aug 13, 2019	BUY	$13.46 - $25.75 $208,414 - $398,713	15,484 New	15,484 $399,000

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account